PHARMACEUTICAL MANUFACTURING

CONTRACT PHARMA MANUFACTURING WHITE PAPERS & ARTICLES

  • The Unique Needs Of The HPAPI Market: Are You Prepared?

    To take advantage of the growing HPAPI market, a company must have the proper controls in place to safely handle these potent compounds and successfully bring its drug to market.

  • The Race to Phase III: A Cautionary Tale of Scalability

    Follow the paths of two companies as they learn how a science-led, risk-based development approach yields a more successful outcome in the long run.

  • Cost Savings And Speed: The Untapped Value Of A Single-Source Solution

    Small and emerging companies face significant challenges in today’s market. This calls for an alternative solution to help them achieve success. One option is a single-source solution, which can eliminate the silos that can often exist in today’s outsourcing paradigm, increasing both communication and speed.

  • Solving the OOS Problem with Continuous Manufacturing

    With continuous manufacturing, it is possible to monitor product quality continuously, and make adjustments in real time to keep the product in spec. And when it isn’t, as will sometimes (albeit rarely) happen, the manufacturer can step in more quickly than ever before to limit the volume of OOS product — saving time, money, and staying ever closer to the ideal quality standard.

  • Avoid The Do-Over: Why Early Investment In A Scalable Manufacturing Process Is Critical

    The failure of drug compounds in mid- to late-stage development is far more common than anyone would like it to be. Only about 30% of compounds successfully transition from Phase II to Phase III.

  • Single-Vendor CDMOs Bring Speed And Cost Savings To The Table

    As drug developers face the ever-pressing need to get molecules to market as efficiently as possible, firms large and small are increasingly turning to CDMOs for help. At a CPhI North America panel on single-source CDMOs, four industry experts discussed how working with a single-source CDMO partner can accelerate time to market, add cost savings, and improve a formulation’s chances of achieving regulatory success.

  • How To Rapidly Create Single-Use Biomanufacturing Capacity

    To meet therapy production demands, the industry needs to have the right capacity, in the right locations. Increasingly, single-use technologies are being seen as flexible and cost-effective solutions.

More From Pharmaceutical Manufacturing White Papers & Articles

CONTRACT PHARMA MANUFACTURING APPLICATIONS & STUDIES

  • Versatility Of Softgel Technology: The Encapsulation Of A Volatile Compound
    Versatility Of Softgel Technology: The Encapsulation Of A Volatile Compound

    A commercial stage medical technology company has developed SMART Softgels featuring a special shell to release quickly while still preventing evaporative loss during and after manufacturing. 

  • Paediatric Drug Product Development Through To Commercialization
    Paediatric Drug Product Development Through To Commercialization

    Almac has developed a flexible paediatric dosage form consisting of minitablets filled into stickpacks using a robust manufacturing and filling process suitable for routine commercial manufacture.

  • Accelerated Fill/Finish CGMP Campaign For A Biologic Drug Product Program
    Accelerated Fill/Finish CGMP Campaign For A Biologic Drug Product Program

    Manufacturing of biological and small molecule drug products is on the rise, and more often than not, generation of stability data and getting product released for clinical trials are on the critical path to approval. Emergent Camden not only understands that, but delivers quality product in timelines significantly shorter than other contract manufacturers.

  • Case Study: Controlled Drug Handling A midsize pharmaceutical company came to Aptuit to work through the complexities of exporting a controlled substance manufactured in the United States and an EU-sourced comparator for inclusion in a clinical trial across more than 12 EU participating countries. Aptuit’s client was dealing with an Investigative Medicinal Product (IMP) manufactured in the United States and an EU-sourced comparator. By Aptuit, Inc.
More From Pharmaceutical Manufacturing Applications & Studies

CONTRACT PHARMA MANUFACTURING SERVICES

CDMO For All Phases Of The Drug Life Cycle CDMO For All Phases Of The Drug Life Cycle

Piramal Pharma Solutions is the contract development and manufacturing (CDMO) arm of Piramal Enterprises Ltd with a vast network of development and manufacturing facilities located in North America, Europe and Asia. 

Contract Development And Manufacturing (CDMO) Formulation Services Contract Development And Manufacturing (CDMO) Formulation Services

Piramal Pharma Solutions is the contract development and manufacturing (CDMO) arm of Piramal Enterprises Ltd., having a vast network of development and manufacturing facilities located in North America, Europe and Asia.

Pharmaceutical Contract Packaging: Quality And Technologies Pharmaceutical Contract Packaging: Quality And Technologies

Our cutting-edge technology and impeccable standards ensure that our customers receive products that meet their exact needs.

API Development & Manufacturing Services API Development & Manufacturing Services

Piramal Pharma Solutions is the contract development and manufacturing (CDMO) arm of Piramal Enterprises Ltd. with a vast network of development and manufacturing facilities in North America,Europe and Asia.

High Potency API (HPAPI) Development & Manufacturing High Potency API (HPAPI) Development & Manufacturing

Piramal Pharma Solutions (PPS) is pleased to welcome Ash Stevens LLC as a part of the Piramal Group. Leveraging five decades of Ash Stevens’s operational experience and technical expertise, Piramal’s service offering now includes High Potency API (HPAPI) development and manufacturing capabilities. Located in Riverview, USA, our state-of the-art FDA licensed cGMP facility offers a full range of scale and containment options for high potency API manufacturing.

More From Pharmaceutical Manufacturing Services

 PHARMACEUTICAL MANUFACTURING EVENTS

Data Analytics for Pharma Development November 28 - 30, 2017
Brussels)
Implementing the ASTM E2500 Validation Method: 10 Years of Key Learnings November 28, 2017
1pm-2:30pm EST, Online Training)
Duration:  90 Minutes
Price:  $299 - Includes Bonus Handouts!
The Top Method Validation Mistakes – And How to Avoid Them November 29, 2017
1pm-2:30pm EST, Online Training)
Duration:  90 Minutes
Price:  $299 - Includes Bonus Handouts!
An Introduction to Good Laboratory Practices (GLP) December 5, 2017
1pm-2:30pm EDT, Online Training)
Duration:  90 Minutes
Price:  $299 - Includes Bonus Handouts!
Quality by Design (QbD): Making Sense of the ICH Q8, Q9, Q10 Puzzle December 6, 2017
1pm-2:30pm EST, Online Training)
Duration:  90 minutes
Price:  $299 - Introductory Rate